Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.58B |
| 2 |
Netflix
NFLX
|
+$496M |
| 3 |
Meta Platforms (Facebook)
META
|
+$275M |
| 4 |
Alibaba
BABA
|
+$215M |
| 5 |
UnitedHealth
UNH
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$926M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$682M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$556M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.18% |
| 2 | Technology | 2.09% |
| 3 | Communication Services | 1.44% |
| 4 | Financials | 1.21% |
| 5 | Healthcare | 1.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RLH
9651
DELISTED
Red Lions Hotel Corporation
RLH
| $71K | ﹤0.01% |
10,978
-1,756
| -14% | -$11K |
|
9652
PUT
Calix
CALX
$2.46B
| $70K | ﹤0.01% |
10,900
+700
| +7% | +$4.41K |
|
9653
CALL
KALA BIO
KALA
$16M
| $70K | ﹤0.01% |
+7
| New | +$85.2K |
|
9654
PUT
ReposiTrak
TRAK
$143M
| $69K | ﹤0.01% |
+11,900
| New | +$66.7K |
|
|
ATRS
9655
CALL
DELISTED
Antares Pharma, Inc.
ATRS
| $69K | ﹤0.01% |
20,600
-151,000
| -88% | -$497K |
|
9656
VEON
VEON
$4.28B
| $68K | ﹤0.01% |
+1,140
| New | +$78.2K |
|
|
WPRT
9657
PUT
Westport Fuel Systems
WPRT
$35M
| $68K | ﹤0.01% |
2,500
-220
| -8% | -$6.25K |
|
9658
Yunhong Green CTI Ltd
YHGJ
$7.62M
| $68K | ﹤0.01% |
3,418
+484
| +16% | +$12.2K |
|
|
CMRX
9659
DELISTED
Chimerix, Inc.
CMRX
| $68K | ﹤0.01% |
29,013
+7,668
| +36% | +$22.1K |
|
|
TYME
9660
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $68K | ﹤0.01% |
57,325
+10,674
| +23% | +$13.5K |
|
9661
BlackRock Income Trust
BKT
$338M
| $67K | ﹤0.01% |
3,670
-3,628
| -50% | -$65.8K |
|
9662
Kinetik
KNTK
$4.43B
| $67K | ﹤0.01% |
2,360
+368
| +18% | +$11K |
|
|
JNCE
9663
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $67K | ﹤0.01% |
20,241
+3,917
| +24% | +$15.7K |
|
|
AVDL
9664
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| $66K | ﹤0.01% |
+15,900
| New | +$39.8K |
|
|
ACOR
9665
DELISTED
Acorda Therapeutics
ACOR
| $66K | ﹤0.01% |
191
-388
| -67% | -$211K |
|
9666
PUT
Vaalco Energy
EGY
$599M
| $65K | ﹤0.01% |
31,900
+1,200
| +4% | +$2.12K |
|
|
9667
PUT
KALA BIO
KALA
$16M
| $65K | ﹤0.01% |
7
-2
| -22% | -$24.3K |
|
9668
Lineage Cell Therapeutics
LCTX
$278M
| $65K | ﹤0.01% |
66,320
-43,670
| -40% | -$45.2K |
|
|
SUP
9669
DELISTED
Superior Industries International
SUP
| $65K | ﹤0.01% |
22,633
-14,639
| -39% | -$42.7K |
|
9670
Forum Energy Technologies
FET
$841M
| $64K | ﹤0.01% |
2,079
+571
| +38% | +$23.5K |
|
9671
Novavax
NVAX
$1.53B
| $64K | ﹤0.01% |
+12,838
| New | +$70.3K |
|
|
INWK
9672
CALL
DELISTED
InnerWorkings, Inc.
INWK
| $64K | ﹤0.01% |
+14,500
| New | +$57.8K |
|
|
BGFV
9673
DELISTED
Big 5 Sporting Goods
BGFV
| $63K | ﹤0.01% |
+30,227
| New | +$59.8K |
|
9674
PUT
Celldex Therapeutics
CLDX
$3.17B
| $63K | ﹤0.01% |
29,600
+3,800
| +15% | +$8.79K |
|
9675
Dynagas LNG Partners
DLNG
$138M
| $63K | ﹤0.01% |
31,576
-49,629
| -61% | -$68.1K |
|
Similar funds
Jeff Yass's Q3 2019 Portfolio in Review
As of Q3 2019, Jeff Yass held 11,380 positions worth $298B, up 8.4% from $275B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $26.9B of net new capital in Q3 2019, opening 1,223 new positions and adding to 4,885 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 1.8% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $926M trimmed.
- Jeff Yass's largest Q3 2019 buy was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
- Jeff Yass added most to Amazon in Q3 2019, an estimated $1.58B increase.
- Jeff Yass's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $926M.
- Jeff Yass fully exited Tableau Software, Inc. in Q3 2019, selling an estimated $179M.
- Jeff Yass's ten largest holdings make up 24% of its $298B portfolio in Q3 2019.
- Jeff Yass opened 1,223 new positions and closed 1,294 in Q3 2019.
- Jeff Yass's portfolio value rose 8.4% quarter-over-quarter to $298B.
Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.